About energy security

Nuclear hardsell's most potent weapon

The inconvenient truth

The US and us

How not to lose all

No more kindergarten approach to climate

Another co2alition of the willing?

2009 is full of promise

What Durban did not discuss

IPRs are blocking access to mitigation and adaptation technologies. India offers a way out

Disclosure-shy industry

Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues

Pact politics

High political drama marks climate negotiations as the European Union strives to ratify the Kyoto protocol without the US, world's biggest polluter

Playing safe

Nations finally draft a treaty to combat the use of toxic chemicals like DDT and PCBs, which are known for their damning health effects

Tangible shift

Bioprocessing - the Indian leather industry braces itself for an environmental facelift

In Obninsk there was a mausoleum

Nuclear power wants to pose as peace, sustainability. But to the world, it has always meant the bomb and danger. What are governments doing to …

One step forward, two steps back

Countries want to do little to keep global average temperature rise to below 2oC. The Warsaw climate talks have exposed this. A report by Uthra …

US says it will not extend commitment on climate mitigation efforts

Ambitions on reducing carbon emissions levels missing at CoP 18, say developing countries

Science and Technology - Briefs

Women, children worst victims of indoor air pollution

Will Robert Zoellick make a better World Bank president?

News - In short

UNFCCC meet fails to secure emission commitments

Equity: the next frontier in climate talks

Can we afford not to change?

COVID-19 unlockdown is a challenge and an opportunity at the same time

It will generate medium-term challenges but also presents an opportunity to accelerate the shift to more sustainable and equitable growth

Loud and unclear

Ethics on trial

Five per cent of the clinical trials conducted across the world will be in India by 2012. They are vital for confirming the efficacy of a new drug,…